Coloplast A/S (OTCPK:CLPBF) Q1 2022 Earnings Conference Call May 05, 2022 09:00 AM ET Company Participants Kristian Villumsen - President & Chief Executive Officer Anders.
. The company reported 2% organic growth in Q2. Reported revenue in DKK was down by 1% to DKK 4,753 million, impacted by the depreciation of the USD and a number of Emerging markets currencies against DKK. The EBIT margin was 33% before special items against 32% last year, which reflects continued strong cost control during the COVID-19 pandemic as well as sustained investments in growth opportunities and innovation. EBIT was impacted by a further DKK 200m provision for costs related to the existing lawsuits in the US alleging injury resulting from the use of transvaginal surgical mesh products. In the first six months of the financial year, organic growth was 4% and the EBIT margin was 33% before special items.